HB2550: Requiring certain 340B entities to report annually to the Kansas department of insurance on certain costs, savings and payments made under the federal 340B drug pricing program.

Who This Affects

Kansans who rely on these organizations for healthcare services will be affected by this reporting requirement. Specifically, patients at hospitals, clinics, and other healthcare facilities that participate in the 340B program may benefit from increased transparency and accountability.